Healthtech startup Gabify, focused on neurodevelopmental care, has raised $175,000 in a pre-seed round led by Inflection Point Ventures. Additionally, the company secured Rs 25 lakh under the Nidhi Seed Support Scheme from GHRTBI.
The funds will be deployed to enhance clinical validation, develop technology, and expand the team, as well as to scale the platform across different models including B2B, B2C, and CSR initiatives. The startup aims to impact one million children by 2028.
About Gabify
Founded in 2023 by Sahil Chopra, Prachi Sood, and Vasyl Leshchuk, Gabify is building an AI-powered platform for early screening and therapy management of speech and neurodevelopmental disorders such as autism and ADHD.
The startup’s mission is to make early intervention accessible, efficient, and scalable, helping children receive timely support and improved long-term outcomes.
How the Funding Will Be Used
The pre-seed investment will be used to:
- Clinical Validation: Test and validate the AI platform with real-world users.
- Technology Development: Enhance AI algorithms for early screening and personalized therapy management.
- Team Expansion: Hire talent to accelerate product development and operations.
- Scaling Outreach: Expand via B2B partnerships, direct-to-consumer channels, and CSR initiatives.
By leveraging AI, Gabify aims to make therapy management more effective and easier to access for families and healthcare providers.
The Vision: Impacting One Million Children
Gabify plans to expand rapidly over the next five years, targeting 1 million children by 2028. By combining technology with clinical expertise, the platform aims to bridge gaps in neurodevelopmental care, ensuring children receive the right intervention at the right time.
This funding marks a critical step in Gabify’s journey to make neurodevelopmental care scalable, affordable, and effective, particularly for underserved communities.
Why It Matters
Early intervention is key in managing neurodevelopmental disorders. By leveraging AI, Gabify can:
- Detect disorders like autism and ADHD sooner
- Improve therapy planning and outcomes
- Reduce burden on families and caregivers
- Expand access to quality care across India
With this funding, Gabify is well-positioned to become a leading player in healthtech solutions for neurodevelopmental disorders.
